US Stock MarketDetailed Quotes
RPID Rapid Micro Biosystems
- 1.040
- -0.040-3.70%
Close Nov 15 16:00 ET
44.76MMarket Cap-928P/E (TTM)
1.095High1.040Low43.12KVolume1.070Open1.080Pre Close45.79KTurnover0.47%Turnover RatioLossP/E (Static)43.03MShares1.34052wk High0.53P/B9.64MFloat Cap0.58052wk Low--Dividend TTM9.27MShs Float27.040Historical High--Div YieldTTM5.09%Amplitude0.580Historical Low1.061Avg Price1Lot Size
Rapid Micro Biosystems Key Stats
Quarterly+Annual
YOY
| (Q3)Sep 30, 2024 | (Q2)Jun 30, 2024 | (Q1)Mar 31, 2024 | (FY)Dec 31, 2023 | (Q4)Dec 31, 2023 | (Q3)Sep 30, 2023 | (Q2)Jun 30, 2023 | (Q1)Mar 31, 2023 | (FY)Dec 31, 2022 | (Q4)Dec 31, 2022 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Operating Cash Flow (Indirect Method) | ||||||||||
| Cash flow from continuing operating activities | 11.41%-8.6M | -10.11%-10.12M | 6.96%-15.53M | 23.00%-45.08M | 18.52%-9.5M | 35.73%-9.71M | 38.68%-9.19M | 0.68%-16.69M | -6.52%-58.55M | 9.56%-11.66M |
| Net income from continuing operations | 15.45%-11.32M | 10.26%-12.58M | 4.07%-13.32M | 13.71%-52.47M | 32.07%-11.17M | 18.04%-13.39M | -7.07%-14.02M | 6.99%-13.89M | 17.30%-60.81M | -12.61%-16.45M |
| Operating gains losses | ---- | ---- | ---- | ---- | ---- | ---- | ---- | ---- | -99.88%28K | --9K |
| Depreciation and amortization | 9.99%859K | 7.39%828K | 6.19%806K | 9.45%3.11M | -7.67%794K | 6.40%781K | 12.88%771K | 35.54%759K | 85.55%2.84M | 91.11%860K |
| Other non cash items | -17.20%260K | 2.95%314K | 2.29%313K | 19.40%1.24M | 1.96%312K | 2.61%314K | 96.77%305K | 13.75%306K | 156.44%1.04M | 2,085.71%306K |
| Change In working capital | -59.43%770K | -83.23%526K | 12.36%-3.99M | 110.42%555K | -97.31%76K | 537.33%1.9M | 177.78%3.14M | -23.48%-4.56M | 33.42%-5.33M | 406.26%2.83M |
| -Change in receivables | 381.82%1.27M | -104.38%-90K | 530.28%611K | 55.22%-163K | -128.87%-1.63M | 19.32%-451K | 878.41%2.06M | -112.15%-142K | -2,041.18%-364K | -71,100.00%-710K |
| -Change in inventory | -76.44%176K | -25,625.00%-1.02M | -359.81%-543K | 120.42%1.19M | 162.80%233K | 275.38%747K | 100.11%4K | 110.24%209K | 13.64%-5.84M | 75.58%-371K |
| -Change in prepaid assets | -64.40%257K | 25.96%917K | -213.08%-415K | -52.94%272K | -311.64%-1.55M | 134.32%722K | -34.59%728K | -56.26%367K | 152.31%578K | -49.55%730K |
| -Change in payables and accrued expense | -182.09%-715K | 20.46%1.53M | 32.18%-3.9M | -58.39%-2.02M | -9.67%1.6M | -65.96%871K | 193.64%1.27M | -35.37%-5.76M | -171.65%-1.28M | 30.94%1.77M |
| -Change in other current assets | -1,178.57%-151K | -92.86%1K | --0 | -97.21%5K | --0 | 193.33%14K | -89.63%14K | 54.90%-23K | 121.03%179K | 155.56%110K |
| -Change in other working capital | -1,260.00%-68K | 13.43%-806K | -67.22%259K | -9.42%1.27M | 8.68%1.42M | 99.03%-5K | -2,638.24%-931K | 22.10%790K | 238.71%1.4M | 365.71%1.3M |
| Cash from discontinued investing activities | ||||||||||
| Operating cash flow | 11.41%-8.6M | -10.11%-10.12M | 6.96%-15.53M | 23.00%-45.08M | 18.52%-9.5M | 35.73%-9.71M | 38.68%-9.19M | 0.68%-16.69M | -6.52%-58.55M | 9.56%-11.66M |
| Investing cash flow | ||||||||||
| Cash flow from continuing investing activities | -237.18%-6.54M | 84.25%24.82M | -2.84%13.52M | 145.10%42.15M | -21.81%10.01M | 153.35%4.77M | 508.63%13.47M | 113.97%13.91M | -603.36%-93.47M | 147.31%12.8M |
| Net PPE purchase and sale | 50.77%-223K | -113.49%-459K | 22.92%-585K | 72.63%-1.85M | 48.46%-418K | 71.46%-453K | 89.19%-215K | 67.74%-759K | -110.82%-6.74M | 58.75%-811K |
| Net investment purchase and sale | -221.00%-6.32M | 84.71%25.28M | -3.88%14.1M | 150.73%44M | -23.40%10.43M | 171.04%5.22M | 225.65%13.68M | 115.09%14.67M | -759.38%-86.73M | 154.24%13.61M |
| Cash from discontinued investing activities | ||||||||||
| Investing cash flow | -237.18%-6.54M | 84.25%24.82M | -2.84%13.52M | 145.10%42.15M | -21.81%10.01M | 153.35%4.77M | 508.63%13.47M | 113.97%13.91M | -603.36%-93.47M | 147.31%12.8M |
| Financing cash flow | ||||||||||
| Cash flow from continuing financing activities | 27.08%61K | -11.11%-10K | 29.51%158K | -78.50%149K | -113.79%-12K | -68.21%48K | -12.50%-9K | -73.65%122K | -99.68%693K | 106.93%87K |
| Net issuance payments of debt | 0.00%-9K | -11.11%-10K | -11.11%-10K | -12.12%-37K | -11.11%-10K | -12.50%-9K | -12.50%-9K | -12.50%-9K | 99.87%-33K | 25.00%-9K |
| Proceeds from stock option exercised by employees | 22.81%70K | --0 | 28.24%168K | -74.38%186K | -102.08%-2K | -64.15%57K | --0 | -72.19%131K | -21.60%726K | 0.00%96K |
| Cash from discontinued financing activities | ||||||||||
| Financing cash flow | 27.08%61K | -11.11%-10K | 29.51%158K | -78.50%149K | -113.79%-12K | -68.21%48K | -12.50%-9K | -73.65%122K | -99.68%693K | 106.93%87K |
| Net cash flow | ||||||||||
| Beginning cash position | 29.14%37.41M | -8.01%22.72M | -10.16%24.57M | -84.69%27.35M | -7.83%24.07M | -42.08%28.96M | -60.67%24.69M | -84.69%27.35M | 492.04%178.67M | -88.12%26.12M |
| Current changes in cash | -208.07%-15.08M | 243.98%14.69M | 30.22%-1.85M | 98.16%-2.78M | -59.50%499K | 79.51%-4.89M | 133.41%4.27M | 97.71%-2.65M | -201.91%-151.32M | 102.99%1.23M |
| End cash Position | -7.24%22.33M | 29.14%37.41M | -8.01%22.72M | -10.16%24.57M | -10.16%24.57M | -7.83%24.07M | -42.08%28.96M | -60.67%24.69M | -84.69%27.35M | -84.69%27.35M |
| Free cash flow | 13.17%-8.82M | -12.47%-10.58M | 7.65%-16.11M | 28.12%-46.93M | 20.46%-9.92M | 39.13%-10.16M | 44.59%-9.41M | 8.92%-17.45M | -12.21%-65.29M | 16.07%-12.47M |
| Currency Unit | USD | USD | USD | USD | USD | USD | USD | USD | USD | USD |
| Accounting Standards | US-GAAP | US-GAAP | US-GAAP | US-GAAP | US-GAAP | US-GAAP | US-GAAP | US-GAAP | US-GAAP | US-GAAP |
| Audit Opinions | -- | -- | -- | Unqualified Opinion | -- | -- | -- | -- | -- | -- |
Analysis
Price Target
No Data
Heat List
US
Overall
Symbol
Latest Price
% Chg
No Data